Flagship of China’s ‘Godfather of Cardiovascular Surgery’ Slices Towards IPO
The maker of cardiovascular interventional medical devices has been approved for a listing on the Hong Kong Stock ExchangeKey Takeaways:OrbusNeich Medical has been approved for a Hong Kong IPO, and…
RELATED ARTICLES
-
Rebounding RLX plots course beyond China
RLX.US -
Airdoc Tech enjoys healing properties of medical AI rally
2251.HK
-
Everest gets boost from core product Nefecon’s inclusion in China’s national health plan
1952.HK
- Cash-strapped Mirxes looks for lifeline in blood-based cancer detection
-
SPONSORED: ARK Wealth outlines global asset allocation strategies at inaugural flagship summit
6686.HK NOAH.US
-
Lopal steers back towards profitability after tough two years
2465.HK 603906.SHG
-
Cash-hungry Mabwell seeks financial tonic from Hong Kong investors
688062.SHG
